missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ OGT 2115
Antiangiogenic. Heparanase inhibitor
N.V.
Spezifikation
Chemischer Name oder Material | 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid |
---|---|
CAS | 853929-59-6 |
Prozentgehaltsbereich | >98% |
Löslichkeit | Soluble to 10mM in DMSO |
Summenformel | C24H16BrFN2O4 |
Beschreibung
Heparanase inhibitor (IC50 = 0.4 μM) that displays no major inhibition of human cytochrome P450 isoenzymes (IC50 > 30 μM). Exhibits antiangiogenic properties in vitro (IC50 = 1 μM).Spezifikation
2-[4-[[3-(4-Bromophenyl)-1-oxo-2-propenyl]amino]-3-fluorophenyl]-5-benzoxazoleacetic acid | |
>98% | |
C24H16BrFN2O4 | |
97% |
853929-59-6 | |
Soluble to 10mM in DMSO | |
Observed MW: 495.3 |
For Research Use Only